References

Agnew W, Korman R. Pharmacological appetite stimulation. J Feline Med Surg. 2014; 16:(9)749-756 https://doi.org/10.1177/1098612X14545273

Alcázar Arroyo R. Electrolyte and acid-base balance disorders in advanced chronic kidney disease. Nefrologia. 2008; 28:87-93

Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019; 33:(2)363-382 https://doi.org/10.1111/jvim.15454

Anderson WI, Picut CA, King JM, Perdrizet JA. Renal dysplasia in a standardbred colt. Vet Pathol.. 1988; 25:(2)179-180 https://doi.org/10.1177/030098588802500217

Andreoli SP. Acute renal failure in the newborn. Semin Perinatol.. 2004; 28:(2)112-123 https://doi.org/10.1053/j.semperi.2003.11.003

Andrews FM, Rosol TJ, Kohn CW, Reed SM, DiBartola SP. Bilateral renal hypoplasia in four young horses. J Am Vet Med Assoc.. 1986; 189:(2)209-212

Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol.. 2011; 22:(11)1981-1989 https://doi.org/10.1681/ASN.2011040414

Banks KL, Henson JB. Immunologically mediated glomerulitis of horses. II. Antiglomerular basement membrane antibody and other mechanisms in spontaneous disease. Lab Invest. 1972; 26:(6)708-715

Banks KL, Henson JB, McGuire TC. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus. Lab Invest. 1972; 26:(6)701-707

Bergström J. Mechanisms of uremic suppression of appetite. J Ren Nutr.. 1999; 9:(3)129-132 https://doi.org/10.1016/S1051-2276(99)90050-X

Brown C, Parks A, Mullaney T, Sonea I, Stickle R. Bilateral renal dysplasia and hypoplasia in a foal with an imperforate anus. Vet Rec.. 1988; 122:(4)91-92 https://doi.org/10.1136/vr.122.4.91

Brown SA, Brown CA, Crowell WA Beneficial effects of chronic administration of dietary ω-3 polyunsaturated fatty acids in dogs with renal insufficiency. J Lab Clin Med. 1998; 131:(5)447-455 https://doi.org/10.1016/S0022-2143(98)90146-9

Carrick JB, Pollitt CC. Chronic pyelonephritis in a brood mare. Aust Vet J.. 1987; 64:(8)252-254 https://doi.org/10.1111/j.1751-0813.1987.tb09696.x

Chandler KJ, Johnston HM, Murphy DM. Polycystic kidney disease in an aged pony. Vet Rec.. 2003; 153:(24)754-756

Clark ES, Becht JL. Clinical pharmacology of the gastrointestinal tract. Vet Clin North Am Equine Pract. 1987; 3:(1)101-122 https://doi.org/10.1016/S0749-0739(17)30693-4

Divers TJ, Timoney JF, Lewis RM, Smith CA. Equine glomerulonephritis and renal failure associated with complexes of Group-C streptococcal antigen and IgG antibody. Vet Immunol Immunopathol.. 1992a; 32:(1-2)93-102 https://doi.org/10.1016/0165-2427(92)90071-W

Divers TJ, Byars TD, Shin SJ. Renal dysfunction associated with infection of Leptospira interrogans in a horse. J Am Vet Med Assoc.. 1992b; 201:(9)1391-1392

Divers TJ, Chang YF, Irby NL, Smith JL, Carter CN. Leptospirosis: an important infectious disease in North American horses. Equine Vet J.. 2019; 51:(3)287-292 https://doi.org/10.1111/evj.13069

Ehnen SJ, Divers TJ, Gillette D, Reef VB. Obstructive nephrolithiasis and ureterolithiasis associated with chronic renal failure in horses: eight cases (1981-1987). J Am Vet Med Assoc.. 1990; 197:(2)249-253

Fassett RG, Gobe GC, Peake JM, Coombes JS. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis.. 2010; 56:(4)728-742 https://doi.org/10.1053/j.ajkd.2010.03.009

Fielding CL. Fluid therapy for renal failure.: Equine Fluid Therapy; 2015 https://doi.org/10.1002/9781118928189.ch14

Frye MA, Johnson JS, Traub-Dargatz JL, Savage CJ, Fettman MJ, Gould DH. Putative uremic encephalopathy in horses: five cases (1978-1998). J Am Vet Med Assoc.. 2001; 218:(4)560-566 https://doi.org/10.2460/javma.2001.218.560

Gilday RA, Wojnarowicz C, Tryon KA, Lohmann KL. Bilateral renal dysplasia, hydronephrosis, and hydroureter in a septic neonatal foal. Can Vet J.. 2015; 56:(3)257-260

Giorgi M, Lavasani H, Sheikholeslami B Pharmacokinetics of mirtazapine and its main metabolites in fasting and fed horses. J Vet Pharmacol Ther.. 2012; 35:(3)167-168 https://doi.org/10.1186%2F2008-2231-22-13

Gough R, McGovern K. Acute renal failure in adult horses. UK-Vet Equine. 2019; 3:(6)216-22 https://doi.org/10.12968/ukve.2019.3.6.216

Gratwick Z. An updated review: laboratory investigation of equine renal disease. Equine Vet Educ.. 2020; 32:(7) https://doi.org/10.1111/eve.13373

Grossman BS, Brobst DF, Kramer JW, Bayly WM, Reed SM. Urinary indices for differentiation of prerenal azotemia and renal azotemia in horses. J Am Vet Med Assoc.. 1982; 180:(3)284-288

Gull T, Schmitz DG, Bahr A, Read WK, Walker M. Renal hypoplasia and dysplasia in an American miniature foal. Vet Rec.. 2001; 149:(7)199-203 https://doi.org/10.1136/vr.149.7.199

Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014; 28:(6)1676-1683 https://doi.org/10.1111/jvim.12445

Held JP, Wright B, Henton JE. Pyelonephritis associated with renal failure in a horse. J Am Vet Med Assoc.. 1986; 189:(6)688-689

International Renal Interest Society. IRIS grading of Acute Kidney Injury. 2016. http://www.iris-kidney.com/pdf/4_ldc-revised-grading-of-acute-kidney-injury.pdf

Irwin DH, Howell DW. Equine pyelonephritis and unilateral nephrectomy. J S Afr Vet Assoc.. 1980; 51:(4)235-236

Jakob W. Spontaneous amyloidosis of mammals. Vet Pathol.. 1971; 8:(4)292-306

Jones SL, Langer DL, Sterner-Kock A, Snyder JR, Carlson GP. Renal dysplasia and benign ureteropelvic polyps associated with hydronephrosis in a foal. J Am Vet Med Assoc.. 1994; 204:(8)1230-4

Juzwiak JS, Bain FT, Slone DE, Santschi EM, Johnson JJ. Unilateral nephrectomy for treatment of chronic hematuria due to nephrolithiasis in a colt. Can Vet J.. 1988; 29:(11)931-3

Khonsary SA. Guyton and Hall: Textbook of Medical Physiology. Surg Neurol Int.. 2017; 8 https://doi.org/10.4103/sni.sni_327_17

Kim DY, Taylor HW, Eades SC, Cho DY. Systemic AL amyloidosis associated with multiple myeloma in a horse. Vet Pathol.. 2005; 42:(1)81-84

Krawiec DR. Managing gastrointestinal complications of uremia’. Vet Clin North Am Small Anim Pract. 1996; 26:(6)1287-92

Matthews HK, Toal RL. A review of equine renal imaging techniques’. Veterinary Radiol Ultrasound. 1996; 37:(3)163-173

McSloy A, Poulsen K, Fisher PJ, Armien A, Chilton JA, Peek S. Diagnosis and treatment of a selective immunoglobulin M glomerulonephropathy in a quarter horse gelding. J Vet Intern Med. 2007; 21:(4)L 874-7

Moeinzadeh F, Shahidi S, Mortazavi M Effects of Omega-3 Fatty Acid Supplementation on Serum Biomarkers, Inflammatory Agents, and Quality of Life of Patients on Hemodialysis. Iran J Kidney Dis.. 2016; 10:(6)381-387

Mouton R, Holder K. Laboratory tests of renal function. Anaesth Intensive Care Medicine. 2006; 7:(7)240-243 https://doi.org/10.1053/j.mpaic.2006.04.003

Naylor RJ, Mair TS, Last R. Severe hyperkalaemia associated with renal dysplasia in a 2-day-old foal. Equine Vet Educ.. 2009; 21:(7)358-363

Nogradi N, Couetil L, Messick J, Stochelski M, Burgess J. Omega-3 Fatty Acid Supplementation Provides an Additional Benefit to a Low-Dust Diet in the Management of Horses with Chronic Lower Airway Inflammatory Disease. J Vet Intern Med. 2015; 29:(1)299-306 https://doi.org/10.1111/jvim.12488

Olano CG, Akram SM, Bhatt H. Uremic Encephalopathy.Treasure Island (FL): StatPearls Publishing; 2021

Osborne CA, Polzin DJ. Azotemia: A review of what's old and what's new. Compend Contin Educ Pract Vet. 1983; (5)

Perna AF, Di Nunzio A, Amoresano A Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients. Biochimie. 2016; 126:97-107 https://doi.org/10.1016/j.biochi.2016.04.018

Piercy RJ, Swardson CJ, Hinchcliff KW. Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses. J Am Vet Med Assoc.. 1998; 212:(2)244-247

Plummer PJ. Congenital renal dysplasia in a 7-month-old quarter horse colt. Vet Clin North Am Equine Pract. 2006; 22:(1)E63-9 https://doi.org/10.1016/j.cveq.2005.12.026

Popkov VA, Silachev DN, Zalevsky AO, Zorov DB, Plotnikov EY. Mitochondria as a Source and a Target for Uremic Toxins. Int J Mol Sci.. 2019; 20:(12) https://doi.org/10.3390%2Fijms20123094

Quimby JM, Lunn KF. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: A masked placebo-controlled crossover clinical trial. Vet J.. 2013; 197:(3)651-655

Reed S, Bayly W, Sellon D. Equine Internal Medicine, 4th edn. In: Schott H, Waldridge B, Bayly W (eds). Saunders: Elsevier; 2018

Roberts MC, Kelly WR. Renal dysfunction in a case of purpura haemorrhagica in a horse. Vet Rec.. 1982; 110:(7)144-6

Ronen N, van Amstel SR, Nesbit JW, van Rensburg IB. Renal dysplasia in two adult horses: clinical and pathological aspects. Vet Rec.. 1993; 132:(11)269-70

Schott HC. Chronic renal failure in horses. Vet Clin North Am Equine Pract. 2007; 23:(3)593-612 https://doi.org/10.1016/j.cveq.2007.10.002

Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int.. 2012; 82:(6)635-42 https://doi.org/10.1038/ki.2012.180

Siwinska N, Zak A, Slowikowska M, Niedzwiedz A, Paslawska U. Serum symmetric dimethylarginine concentration in healthy horses and horses with acute kidney injury. BMC Veterinary Research. 2020; 16:(1) https://doi.org/10.1186/s12917-020-02621-y

Sullins KE, McIlwraith CW, Yovich JV, MacHarg MA, Fessler J. Ectopic ureter managed by unilateral nephrectomy in two female horses. Equine Vet J.. 1988; 20:(6)463-6

Tennant B, Lowe JE, Tasker JB. Hypercalcemia and hypophosphatemia in ponies following bilateral nephrectomy. Proc Soc Exp Biol Med. 1981; 167:(3)365-8 https://doi.org/10.3181/00379727-167-41180

Trotter GW, Brown CM, Ainsworth DM. Unilateral nephrectomy for treatment of a renal abscess in a foal. J Am Vet Med Assoc.. 1984; 184:(11)1392-4

Tyner GA, Nolen-Walston RD, Hall T A multicenter retrospective study of 151 renal biopsies in horses. J Vet Intern Med. 2011; 25:(3)532-539 https://doi.org/10.1111/j.1939-1676.2011.0700.x

Vaden SL, Breitschwerdt EB, Armstrong PJ The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. J Vet Intern Med. 1995; 9:(4)259-266

Vaziri ND. Oxidative stress in uremia: Nature, mechanisms, and potential consequences. Semin Nephrol.. 2004; 24:(5)469-473 https://doi.org/10.1016/j.semnephrol.2004.06.026

Chronic kidney disease in adult horses: causes, diagnosis and management

02 September 2021
17 mins read
Volume 5 · Issue 5
Figure 1. Ventral oedema.
Figure 1. Ventral oedema.

Abstract

Chronic kidney disease is a rare disease in horses, unlike humans and companion animals where it is frequently encountered. There are multiple causes, although, since the disease typically presents late in the disease process, the instigating factor is often not ascertained. Clinical signs most commonly include weight loss, ventral oedema and polyuria-polydipsia. There is a need for more sensitive markers of renal damage or dysfunction so that the disease can be detected earlier in its course. Serum symmetric dimethylarginine and neutrophil gelatinase-associated lipocalin are potential biomarkers that are being investigated in this regard. Currently, once the diagnosis has been made, treatment is supportive only, with no options to halt the progression of the disease. Although this is a terminal condition, horses can be maintained with an adequate quality of life for several years after diagnosis in some cases.

Chronic kidney disease in horses is a rare diagnosis, with one study finding a prevalence of 0.12% in a hospitalised population, increasing to 0.23% in horses over the age of 15 (Reed et al, 2018). This is far lower than in companion animals, where the overall prevalence is reported to be 0.9% in dogs and 1.6% in cats (Reed et al, 2018). However, the prevalence in horses is likely underestimated as many older horses presenting to the ambulatory veterinarian will be euthanased without a specific diagnosis or referral to a hospital.

Chronic kidney disease is a progressive, terminal condition. The aim is to detect abnormalities as early as possible in the disease process and, with appropriate management strategies, maintain an acceptable quality of life until the point at which euthanasia is required on humane grounds. The rate of progression cannot accurately be predicted, as survival following diagnosis can vary from several months to over 2 years (Schott, 2018).

Register now to continue reading

Thank you for visiting UK-VET Equine and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.